MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Insys Therapeutics Company Profile (NASDAQ:INSY)

Consensus Ratings for Insys Therapeutics (NASDAQ:INSY) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $25.80 (104.44% upside)

Analysts' Ratings History for Insys Therapeutics (NASDAQ:INSY)
Show:
DateFirmActionRatingPrice TargetActions
4/30/2016OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016Janney Montgomery ScottInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016RBC CapitalReiterated RatingOutperform$44.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Jefferies GroupLower Price TargetBuy$23.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Piper JaffrayLower Price TargetOverweight$46.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$38.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Insys Therapeutics (NASDAQ:INSY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
4/28/2016Q116$0.07$0.11$61.31 million$62.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415$0.29$0.36$91.04 million$91.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315$0.23$0.50$82.98 million$91.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215$0.21$0.21$74.06 million$77.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$0.35$0.63$70.90 million$70.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q414$0.44$0.53$63.50 million$66.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2014Q314$0.29$0.63$57.10 million$58.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q214$0.30$0.58$52.77 million$55.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114$0.28$0.23$45.63 million$41.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014Q413$0.55$0.71$34.73 million$40.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3$0.33$0.58$27.00 million$29.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2013Q213$0.12$0.35$15.07 million$18.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/3/2013Q113$0.01$2.00 million$11.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Insys Therapeutics (NASDAQ:INSY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.05$0.05$0.05
Q2 20161$0.04$0.04$0.04
Q3 20161$0.10$0.10$0.10
Q4 20161$0.14$0.14$0.14
(Data provided by Zacks Investment Research)
Dividend History for Insys Therapeutics (NASDAQ:INSY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Insys Therapeutics (NASDAQ:INSY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/6/2016Theodore H StanleyDirectorSell16,000$16.27$260,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016John N Kapoor Trust Dated SeptMajor ShareholderBuy50,000$12.84$642,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Patrick FourteauDirectorSell15,000$18.22$273,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015John N Kapoor Trust Dated SeptMajor ShareholderBuy5,000$29.50$147,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015John N Kapoor Trust Dated SeptMajor ShareholderBuy10,000$26.58$265,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Patrick FourteauDirectorSell30,000$26.48$794,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Theodore H. StanleyDirectorSell4,000$37.04$148,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Fosse Franc DelGeneral CounselSell10,000$34.48$344,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2015Steven J MeyerDirectorSell5,000$63.00$315,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015Brian TambiDirectorSell3,100$60.09$186,279.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Brian TambiDirectorSell1,800$60.00$108,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Patrick FourteauDirectorSell9,064$60.00$543,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015Darryl S BakerCFOSell10,000$59.17$591,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015Steven J MeyerDirectorSell18,000$57.06$1,027,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2015Michael L BabichCEOSell75,000$58.63$4,397,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2015Patrick FourteauDirectorSell10,000$59.94$599,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Theodore H StanleyDirectorSell3,300$60.03$198,099.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Darryl S BakerCFOSell30,000$52.23$1,566,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Patrick FourteauDirectorSell25,000$39.11$977,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014Michael L BabichCEOSell80,000$38.66$3,092,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Theodore H StanleyDirectorBuy3,000$33.93$101,790.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014John N KapoorDirectorBuy5,000$26.13$130,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014John N KapoorDirectorBuy5,000$25.44$127,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2014John N KapoorDirectorBuy20,000$24.84$496,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014John N KapoorDirectorBuy20,000$24.54$490,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Theodore StanleyDirectorBuy4,000$21.94$87,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Patrick FourteauDirectorBuy7,500$22.77$170,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014Larry DillahaInsiderSell149,932$74.57$11,180,429.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014Michael BabichCEOSell288,432$74.58$21,511,258.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Darryl BakerCFOSell10,000$49.61$496,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014Darryl BakerCFOSell10,000$47.54$475,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Darryl BakerCFOSell10,000$45.64$456,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013John KapoorDirectorSell27,428$47.25$1,295,973.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Michael BabichCEOBuy1,000$24.90$24,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Patrick FourteauDirectorBuy5,000$23.77$118,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Michael L BabichCEOBuy1,250$10.93$13,662.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Pierre LapalmeDirectorBuy3,000$10.39$31,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Patrick FourteauDirectorBuy5,000$10.90$54,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Patrick FourteauDirectorBuy4,800$10.90$52,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2013Patrick FourteauDirectorBuy50,000$8.36$418,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Insys Therapeutics (NASDAQ:INSY)
DateHeadline
06/20/16 09:23 AMCompany Shares of Insys Therapeutics Drops by -7.36% - Trade Calls
06/19/16 04:14 PMInsys Therapeutics, Inc. (INSY) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 04:09 PMScott+Scott, Attorneys at Law, LLP Announces Investigation of INSYS Therapeutics, Inc. (NASDAQ: INSY) - GlobeNewswire (press release)
06/15/16 04:43 PMPrice Target by Brokers: Zillow Group, Inc. (NASDAQ:Z), INSYS Therapeutics, Inc. (NASDAQ:INSY) - Beacon Chronicle
06/15/16 04:43 PMStay Far Away From Insys - Seeking Alpha
06/13/16 07:19 AMINSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : June 13, 2016 -
06/12/16 04:34 PM2 Ex-InSys Staffers Charged Over Fentanyl Kickback Scheme
06/11/16 04:45 PMAnalysts Observing Stocks: Insys Therapeutics, Inc. (NASDAQ:INSY) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Street Updates
06/11/16 07:27 AMInsys Therapeutics Inc. (INSY) Drops 5.43% on June 09 - Equities.com
06/10/16 04:50 PMCan Insys Therapeutics, Inc. (NASDAQ:INSY) Keep Up with Analyst Expectations? - Investor Newswire
06/10/16 02:28 PMFormer Insys employees charged in doctor kickback scheme -
06/07/16 04:50 PMInsys Therapeutics Inc. (INSY) Jumps 6.28% on June 06 - Equities.com
06/07/16 04:50 PMInsys Therapeutics Inc. (INSY) Jumps 6.28% on June 06 - Equities.com
06/06/16 04:34 PMTrade-Ideas: Insys Therapeutics (INSY) Is Today's "Dead Cat Bounce" Stock - TheStreet.com
06/06/16 08:15 AMNext Weeks Broker Price Targets For Insys Therapeutics, Inc. (INSY) - Share Trading News
06/04/16 04:39 PMInsys Therapeutics, Inc. (NASDAQ:INSY) Stock Update & Estimates - Stock Tick Tock
06/03/16 07:22 AMInsys Therapeutics Inc. (INSY) is Trading Higher on Unusual Volume for June 01 - Equities.com - Insys Therapeutics Inc. (INSY) is Trading Higher on Unusual Volume for June 01Equities.comInsys Therapeutics Inc. (INSY) experienced unusually high volume on Jun. 01, as the stock gained 7.28% to a closing price of $16.79. The stock saw 878,932 shares trade hands over the course of the day on 6,834 trades. Given that the stock's average ...
06/03/16 07:22 AMFentanyl Claims Prince - What It Means To You - Seeking Alpha - Seeking AlphaFentanyl Claims Prince - What It Means To YouSeeking AlphaINSYS Therapeutics (NASDAQ:INSY), with Subsys, whose active ingredient is fentanyl - precisely the drug said to have claimed Prince's life. ... To combat opioid abuse, companies are seeking to add abuse-deterrence characteristics to their products.and more »
06/02/16 04:55 PMTwo Buzzers within Traders Radar : Orexigen Therapeutics, Inc. (NASDAQ:OREX) , Insys Therapeutics, Inc. (NASDAQ ... - Street Updates - Two Buzzers within Traders Radar : Orexigen Therapeutics, Inc. (NASDAQ:OREX) , Insys Therapeutics, Inc. (NASDAQ ...Street UpdatesIn the past trading session, Insys Therapeutics, Inc. (NASDAQ:INSY) ended trading session higher at $16.79 with +7.28%. The company traded a volume of 881.57 thousand shares as comparison to average volume of 712.38 thousand shares. During the 52 ...Insys Therapeutics Inc. (INSY) Jumps 7.28% on June 01Equities.comInsys Therapeutics Inc (NASDAQ:INSY)'s Company Shares Increased 8.38% After High VolatilityFranklin IndependentUpgrades And Downgrades For Insys Therapeutics, Inc. (INSY)Risers & FallersHNNall 5 news articles »
06/02/16 04:55 PMTwo Buzzers within Traders Radar : Orexigen Therapeutics, Inc. (NASDAQ:OREX) , Insys Therapeutics, Inc. (NASDAQ ... - Street Updates - Two Buzzers within Traders Radar : Orexigen Therapeutics, Inc. (NASDAQ:OREX) , Insys Therapeutics, Inc. (NASDAQ ...Street UpdatesIn the past trading session, Insys Therapeutics, Inc. (NASDAQ:INSY) ended trading session higher at $16.79 with +7.28%. The company traded a volume of 881.57 thousand shares as comparison to average volume of 712.38 thousand shares. During the 52 ...Insys Therapeutics Inc. (INSY) Jumps 7.28% on June 01Equities.comInsys Therapeutics Inc (NASDAQ:INSY)'s Company Shares Increased 8.38% After High VolatilityFranklin IndependentUpgrades And Downgrades For Insys Therapeutics, Inc. (INSY)Risers & FallersHNNall 5 news articles »
06/02/16 07:27 AMInsys Therapeutics Inc. (INSY) Jumps 7.28% on June 01 - Equities.com - Insys Therapeutics Inc. (INSY) Jumps 7.28% on June 01Equities.comInsys Therapeutics Inc. (INSY) was among the biggest gainers on the Russell 2000 for Wednesday June 01 as the stock popped 7.28% to $16.79, representing a gain of $1.14 per share. Some 878,932 shares traded hands on 6,834 trades, compared with an ...Insys Therapeutics Inc (NASDAQ:INSY)'s Company Shares Increased 8.38% After High VolatilityFranklin IndependentUpgrades And Downgrades For Insys Therapeutics, Inc. (INSY)Risers & FallersWhat Will Happen to Insys Therapeutics Inc Next? The Stock Formed a Several Months Wedge DownHNNall 5 news articles »
06/01/16 07:23 AMStock Review and Earnings Check on Insys Therapeutics, Inc. (NASDAQ:INSY) - HNN - Stock Review and Earnings Check on Insys Therapeutics, Inc. (NASDAQ:INSY)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Insys Therapeutics, Inc.and more »
05/31/16 04:49 PMHC Stocks in Focus: Seattle Genetics, Inc. (NASDAQ:SGEN), Insys Therapeutics Inc (NASDAQ:INSY) - share market updates (press release) - HC Stocks in Focus: Seattle Genetics, Inc. (NASDAQ:SGEN), Insys Therapeutics Inc (NASDAQ:INSY)share market updates (press release)Shares of Seattle Genetics, Inc. (NASDAQ:SGEN) ended Friday session in green amid volatile trading. The shares closed up +0.65 points or 1.64% at $40.24 with 755,807.00 shares getting traded. Post opening the session at $39.65, the shares hit an ...
05/31/16 04:49 PMWhat Will Happen to Insys Therapeutics Inc Next? The Stock Formed a Several Months Wedge Down - HNN - What Will Happen to Insys Therapeutics Inc Next? The Stock Formed a Several Months Wedge DownHNNThe stock of Insys Therapeutics Inc (INSY) formed a down wedge with $14.24 target or 9.00% below today's $15.65 share price. The 8 months wedge indicates high risk for the $1.13 billion company. If the $14.24 price target is reached, the company will ...
05/31/16 09:01 AMStock Rating Review for Insys Therapeutics, Inc. (NASDAQ:INSY) - HNN - Stock Rating Review for Insys Therapeutics, Inc. (NASDAQ:INSY)HNNInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.5 on shares of Insys Therapeutics, Inc. (NASDAQ:INSY). Covering ...
05/31/16 09:01 AMStock Paining Investors: INSYS Therapeutics, Inc. (NASDAQ:INSY) - HNN - Stock Paining Investors: INSYS Therapeutics, Inc. (NASDAQ:INSY)HNNWhen a company shows a steady upwards earnings trend, it is a good indicator that the company will dominate companies with a more volatile earnings trend. INSYS Therapeutics, Inc. (NASDAQ:INSY)'s trailing 12 months EPS is 0.7. Last year, their EPS ...and more »
05/31/16 09:01 AMMost recent Trading report: Insys Therapeutics, Inc. (NASDAQ:INSY) , ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ) - Street Updates - Most recent Trading report: Insys Therapeutics, Inc. (NASDAQ:INSY) , ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ)Street UpdatesInsys Therapeutics, Inc. (NASDAQ:INSY) accumulated +0.82%, closing at $15.96 after floating between $15.24 and $16.03. The company has market capitalization of $1.14B. It has twelve month low of $12.21 and twelve month high of $46.17. The recent ...and more »
05/28/16 09:44 AMInsys Therapeutics, Inc. to Present at Two Upcoming Conferences in June - GlobeNewswire (press release) - Insys Therapeutics, Inc. to Present at Two Upcoming Conferences in JuneGlobeNewswire (press release)PHOENIX, May 26, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that Darryl Baker, Chief Financial Officer, and Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical ...Insys Therapeutics Inc (INSY) Jumps 7.5% on May 25Equities.comInsys Therapeutics, Inc. (INSY) Latest Broker CoverageRisers & FallersInsys Therapeutics, Inc. (NASDAQ:INSY) Quarterly EPS From Continuing Operations Stands At $0.034Vanguard TribuneFranklin Independent -News Tribune -share market updates (press release)all 21 news articles »
05/26/16 03:30 PMInsys Therapeutics, Inc. to Present at Two Upcoming Conferences in June - [GlobeNewswire] - PHOENIX, May 26, 2016-- Insys Therapeutics, Inc. today announced that Darryl Baker, Chief Financial Officer, and Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical Officer, will present ...
05/26/16 07:20 AMINSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : May 26, 2016 -
05/26/16 05:11 AMInsys Therapeutics Inc (INSY) Jumps 7.5% on May 25 - Equities.com - Insys Therapeutics Inc (INSY) Jumps 7.5% on May 25Equities.comInsys Therapeutics Inc (INSY) was among the biggest gainers on the Russell 2000 for Wednesday May 25 as the stock popped 7.5% to $16.34, representing a gain of $1.14 per share. Some 1.03 million shares traded hands on 7,968 trades, compared with an ...What's Propelling Insys Therapeutics Inc to Increase So Much?Franklin IndependentScorching Hot Biotech Stocks Tape: Titan Pharmaceuticals (TTNP), INSYS Therapeutics (INSY)ZergwatchInsys Therapeutics, Inc. (NASDAQ:INSY) Closes At $14.33Investor NewswireIs stories -Investing News Network (press release) (registration) (blog) -Sonoran Weekly Reviewall 14 news articles »
05/25/16 11:40 AMEarnings Review and Stock Rundown for Insys Therapeutics, Inc. (NASDAQ:INSY) - Wall Street Hints and News - Earnings Review and Stock Rundown for Insys Therapeutics, Inc. (NASDAQ:INSY)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Insys Therapeutics, Inc. (NASDAQ:INSY) to ...Hold Calls Count For Insys Therapeutics, Inc. (NASDAQ:INSY) At 1Equities Focusall 165 news articles »
05/24/16 05:51 AM6:51 am Insys Therapeutics announces 'successful' completion of phase 1/phase 2 safety & pharmacokinetic study in pediatric subjects with treatment-resistant epilepsy being treated with cannabidiol oral solution -
05/24/16 05:50 AMInsys Therapeutics Successfully Completes Safety and Pharmacokinetic (PK) Study of Cannabidiol Oral Solution in Pediatric Epilepsy Patients - [GlobeNewswire] - PHOENIX, May 24, 2016-- Insys Therapeutics, Inc. today announced that it has successfully completed its Phase 1/ Phase 2 safety and pharmacokinetic study in pediatric subjects with treatment-resistant ...
05/23/16 01:48 PMStock Rating Review for Insys Therapeutics, Inc. (NASDAQ:INSY) - Wall Street Hints and News - Stock Rating Review for Insys Therapeutics, Inc. (NASDAQ:INSY)Wall Street Hints and NewsInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.5 on shares of Insys Therapeutics, Inc. (NASDAQ:INSY). Covering ...and more »
05/21/16 11:31 AMInsys Therapeutics Inc (INSY) Jumps 5.54% on May 20 - Equities.com - Insys Therapeutics Inc (INSY) Jumps 5.54% on May 20Equities.comInsys Therapeutics Inc (INSY) was among the biggest gainers on the Russell 2000 for Friday May 20 as the stock popped 5.54% to $14.09, representing a gain of $0.74 per share. Some 315,484 shares traded hands on 2,485 trades, compared with an ...and more »
05/21/16 11:31 AMINSYS Therapeutics, Inc. Pipeline Review, Industry Analysis, Market Size and Forecast 2016 to 2020 - Medgadget.com (blog) - INSYS Therapeutics, Inc. Pipeline Review, Industry Analysis, Market Size and Forecast 2016 to 2020Medgadget.com (blog)“INSYS Therapeutics, Inc. Global 2015 Clinical Trials Review, H2” provides an detailed overview of INSYS Therapeutics, Inc. scenario. Report includes top line data relating on INSYS Therapeutics, Inc. Global clinical trials scenario. This report on ...and more »
05/20/16 11:54 AMInsiders Are Buying INSYS Therapeutics, Inc. (NASDAQ:INSY) - Wall Street Hints and News - Insiders Are Buying INSYS Therapeutics, Inc. (NASDAQ:INSY)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at INSYS Therapeutics, Inc. (NASDAQ:INSY) have increased their position in the stock by 33.45%. Insiders now own 0.20% of total outstanding shares. There are both legal and illegal types of insider trading.and more »
05/20/16 11:54 AMSignificant Movements: Intersect ENT, Inc. (NASDAQ:XENT) , Insys Therapeutics, Inc. (NASDAQ:INSY) - Street Updates - Significant Movements: Intersect ENT, Inc. (NASDAQ:XENT) , Insys Therapeutics, Inc. (NASDAQ:INSY)Street UpdatesInsys Therapeutics, Inc. (NASDAQ:INSY) after beginning at $13.71, closed at $13.35 by cutting down -1.77% in recent trading session. Most recent session's volume of 387.79 thousand shares lower than its average volume of 726.27 thousand shares.Insys Therapeutics Incorporated (NASDAQ:INSY) Shorted Shares Decreased By 2.79%Wall Street Hints and Newsall 2 news articles »
05/19/16 11:32 AMActive Stocks to Watch: Wi-Lan Inc. (NASDAQ:WILN), INSYS Therapeutics (NASDAQ:INSY), Global Power Equipment ... - KC Register - Active Stocks to Watch: Wi-Lan Inc. (NASDAQ:WILN), INSYS Therapeutics (NASDAQ:INSY), Global Power Equipment ...KC RegisterOn 9 May, Wi-Lan Inc. (NASDAQ:WILN) announced that its wholly-owned subsidiary, IPA Technologies Inc., has acquired a portfolio of nine patents from SRI International. The patented technology relates to the “intelligent personal assistants” found in ...
05/19/16 11:32 AMShare Recap and Earnings Focus on Insys Therapeutics, Inc. (NASDAQ:INSY) - Wall Street Hints and News - Share Recap and Earnings Focus on Insys Therapeutics, Inc. (NASDAQ:INSY)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating Insys Therapeutics, Inc.and more »
05/18/16 12:18 PMInvestigation for Long-Term Investors in Shares of Insys Therapeutics Inc (NASDAQ:INSY) Announced - An investigation on behalf of current long term investors in NASDAQ:INSY shares over possible breaches of fiduciary duty by certain directors of Insys Therapeutics Inc was announced and NASDAQ:INSY stockholders should contact the Shareholders Foundation ...
05/18/16 12:18 PMINSYS Therapeutics Inc. – Product Pipeline Review – 2016 - ‘INSYS Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the INSYS Therapeutics, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by ...
05/17/16 12:30 PMInsys Therapeutics Incorporated (NASDAQ:INSY) Short Interest Decreased By 2.79% - Wall Street Hints and News - Insys Therapeutics Incorporated (NASDAQ:INSY) Short Interest Decreased By 2.79%Wall Street Hints and NewsInsys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The company has a market cap of $944.25 million. The Firm develops and commercializes supportive care products. It has a 18.49 P/E ratio. The Company's product Subsys, ...and more »
05/13/16 06:04 AMEarnings Report of the Stock: Insys Therapeutics Inc (NASDAQ:INSY) - News Oracle - Earnings Report of the Stock: Insys Therapeutics Inc (NASDAQ:INSY)News OracleLast Trade: The Company fell -5.09% and finished at $12.68. The daily volume was measured at 473,733.00 shares. The 52-week high of the share price is $46.17 and the 52-week low is $12.50. The company has a market cap of $887.29 million. The stock ...and more »
05/13/16 06:04 AMInsys Therapeutics Inc (INSY) Drops 5.09% on May 11 - Equities.com - Insys Therapeutics Inc (INSY) Drops 5.09% on May 11Equities.comInsys Therapeutics Inc (INSY) was one of the Russell 2000's biggest losers for Wednesday May 11 as the stock slid 5.09% to $12.68, a loss of $-0.68 per share. Starting at an opening price of $13.27 a share, the stock traded between $12.60 and $13.33 ...Insys Therapeutics, Inc. (NASDAQ:INSY): Stock Target from AnalystsNews TribuneWhat's Next for Insys Therapeutics Inc After Reaching 52-Week Low?The PostJohn N Kapoor Trust Dated September 20 1989 Who Is Insys Therapeutics Inc (NASDAQ:INSY) Insider, Purchased ...Franklin Independentall 4 news articles »
05/12/16 12:04 PMINSYS THERAPEUTICS, INC. Financials -
05/12/16 06:14 AMHere's Why Insys Therapeutics Inc. Fell 14.3% in April - Motley Fool - Motley FoolHere's Why Insys Therapeutics Inc. Fell 14.3% in AprilMotley FoolWhat: Shares of Insys Therapeutics (NASDAQ:INSY) dropped by more than 14% in April, according to data from S&P Global Market Intelligence. The decline was primarily caused by the company warning investors that its first-quarter results were going to ...Insys Therapeutics, Inc. (INSY) Latest Broker ViewsRisers & FallersAre Analysts Bearish Insys Therapeutics Inc (NASDAQ:INSY) After Last Week?Franklin IndependentInsys Therapeutics Inc (NASDAQ:INSY) Quarterly Sentiment ReportThe PostB.O.D.Y Confidentialall 6 news articles »
05/10/16 01:48 PMHere's Why Insys Therapeutics Inc. Fell 14.3% in April - Warnings of terrible first-quarter results send traders running.
05/10/16 05:55 AMCheck on Analyst Ratings Insys Therapeutics, Inc. (NASDAQ:INSY) - B.O.D.Y Confidential - Check on Analyst Ratings Insys Therapeutics, Inc. (NASDAQ:INSY)B.O.D.Y ConfidentialCovering Wall Street analysts have an average rating of 1.5 on shares of Insys Therapeutics, Inc. (NASDAQ:INSY). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating falls on a 1 to 5 scale.and more »
About Insys Therapeutics

Insys Therapeutics logoInsys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company has two marketed products: Subsys, a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and Dronabinol SG Capsule, a generic equivalent to Marinol (dronabinol), an approved second-line treatment of chemotherapy-induced nausea and vomiting (CINV), and anorexia associated with weight loss in patients with AIDS. The Company's lead product candidate is Dronabinol oral solution, an orally administered liquid formulation of dronabinol. Dronabinol oral solution has demonstrated more rapidly detectable blood levels and a more reliable absorption profile than Marinol in its clinical studies.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: INSY
  • CUSIP:
Key Metrics:
  • Previous Close: $12.62
  • 50 Day Moving Average: $14.28
  • 200 Day Moving Average: $18.35
  • P/E Ratio: 18.24
  • P/E Growth: 1.26
  • Market Cap: $902.91M
  • Current Quarter EPS Consensus Estimate: $0.37 EPS
Additional Links:
Insys Therapeutics (NASDAQ:INSY) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha